This ticker has not been starred yet ACRS Aclaris Therapeutics, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 2.75
Leverage 28.74%
Market Cap $ 165.3m
PE 0.00
Dividend Yield 0.00%
Profit $ -129.2m
Margin -452.92%

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a line of novel small molecule therapeutics to address the needs of patients with immuno-inflammatory diseases. The company is headquartered in Wayne, Pennsylvania.

Subscribe Now For Access - Only $1.99 Per Month